Media Summary: Dr. Derek Welch didn't have a roadmap when PathGroup set out to go digital. He built one. The result: a 200+ pathologist practice ... Most VPs and Directors know how to execute deals. Far fewer know how to originate them. In this video, we break down 10 of the ... During SC14 John Biddiscombe (CSCS) gave at the hpc-ch a ParaView demo of Bonsai running on Cray XC30 “Piz Daint” at ...

Don Liscombe Vp Site Head - Detailed Analysis & Overview

Dr. Derek Welch didn't have a roadmap when PathGroup set out to go digital. He built one. The result: a 200+ pathologist practice ... Most VPs and Directors know how to execute deals. Far fewer know how to originate them. In this video, we break down 10 of the ... During SC14 John Biddiscombe (CSCS) gave at the hpc-ch a ParaView demo of Bonsai running on Cray XC30 “Piz Daint” at ... It isn't surprising that Amy Rosenthal, the executive Dale Laird, PhD, explains the role of gap junctions in disease and how his lab at Western University's Schulich School of Medicine ... PharmacyPodcast Bruce Kneeland Interviews President Kevin Minassian, and

As the medical device clinical trial market is rapidly growing, so are the opportunities to augment traditional study designs with ...

Photo Gallery

Meet our Site Head Don Liscombe, Vice President and Site Head of our API facility in Aurora, Canada.
Don Liscombe, VP & Site Head at Piramal Pharma Solutions | Pharma Innovation & Operations
No Blueprint, No Limits: How One Leader Built Digital Pathology Across 12 Sites and 4 Million Sl...
The VP & Director Origination Clinic: 10 Real Problems, 10 Fixes
Interview with John Biddiscombe (CSCS) about remote in-situ visualization at SC14
Rosenthal says pharma must do its part
Profiles of Excellence : Dale  Laird, PhD
Pharmacy Podcast Network:  Bruce Kneeland Interviews Datascan's President and VP
6   UN Consolidates Below 38th Parallel
SCOPE 2022: Comparing Virtual and Traditional Sites in a Pivotal Medical Device Trial
View Detailed Profile
Meet our Site Head Don Liscombe, Vice President and Site Head of our API facility in Aurora, Canada.

Meet our Site Head Don Liscombe, Vice President and Site Head of our API facility in Aurora, Canada.

Don Liscombe

Don Liscombe, VP & Site Head at Piramal Pharma Solutions | Pharma Innovation & Operations

Don Liscombe, VP & Site Head at Piramal Pharma Solutions | Pharma Innovation & Operations

In this episode of Digital Leaders Club,

No Blueprint, No Limits: How One Leader Built Digital Pathology Across 12 Sites and 4 Million Sl...

No Blueprint, No Limits: How One Leader Built Digital Pathology Across 12 Sites and 4 Million Sl...

Dr. Derek Welch didn't have a roadmap when PathGroup set out to go digital. He built one. The result: a 200+ pathologist practice ...

The VP & Director Origination Clinic: 10 Real Problems, 10 Fixes

The VP & Director Origination Clinic: 10 Real Problems, 10 Fixes

Most VPs and Directors know how to execute deals. Far fewer know how to originate them. In this video, we break down 10 of the ...

Interview with John Biddiscombe (CSCS) about remote in-situ visualization at SC14

Interview with John Biddiscombe (CSCS) about remote in-situ visualization at SC14

During SC14 John Biddiscombe (CSCS) gave at the hpc-ch a ParaView demo of Bonsai running on Cray XC30 “Piz Daint” at ...

Rosenthal says pharma must do its part

Rosenthal says pharma must do its part

It isn't surprising that Amy Rosenthal, the executive

Profiles of Excellence : Dale  Laird, PhD

Profiles of Excellence : Dale Laird, PhD

Dale Laird, PhD, explains the role of gap junctions in disease and how his lab at Western University's Schulich School of Medicine ...

Pharmacy Podcast Network:  Bruce Kneeland Interviews Datascan's President and VP

Pharmacy Podcast Network: Bruce Kneeland Interviews Datascan's President and VP

PharmacyPodcast Bruce Kneeland Interviews @datascanpharmacysoftware564 President Kevin Minassian, and

6   UN Consolidates Below 38th Parallel

6 UN Consolidates Below 38th Parallel

6 UN Consolidates Below 38th Parallel

SCOPE 2022: Comparing Virtual and Traditional Sites in a Pivotal Medical Device Trial

SCOPE 2022: Comparing Virtual and Traditional Sites in a Pivotal Medical Device Trial

As the medical device clinical trial market is rapidly growing, so are the opportunities to augment traditional study designs with ...